Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: An observational meta-analysis

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 2, 2011, Pages 202-212

  Zamani, Payman ^a,b,c   Kinlay, Scott ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Cardiovascular Division   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AORTA BIFURCATION; ARTICLE; BARE METAL STENT; COCHRANE LIBRARY; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; STENT THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; METALS; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79751473148     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22750     Document Type: Article

References (68)

1. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678. (Pubitemid 46281313)
2. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. (Pubitemid 40617065)
3. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-1113.
4. Al Suwaidi J, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR Jr,. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol 2001; 87: 1139-1144. (Pubitemid 32453231)
5. Garot P, Lefevre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR Jr,. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: A report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol 2005; 46: 606-612. (Pubitemid 41132685)
6. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007; 50: 463-470. (Pubitemid 47088133)
7. Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, Resnic FS, Normand SL,. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 2008; 118: 1817-1827.
8. Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357: 1393-1402. (Pubitemid 47541971)
9. Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007; 297: 1992-2000. (Pubitemid 46740351)
10. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L,., Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019. (Pubitemid 46376801)
11. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C,. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591. (Pubitemid 44881238)
12. Win HK, Caldera AE, Maresh K, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297: 2001-2009. (Pubitemid 46740352)
13. Farb A, Boam AB,. Stent thrombosis reduxâthe FDA perspective. N Engl J Med 2007; 356: 984-987. (Pubitemid 46376798)
14. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR, Jr., Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB,. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249. (Pubitemid 38372783)
15. Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T, Kuebler P, Buttner HJ, Neumann FJ,. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J 2008; 29: 2859-2867.
16. Pan M, de Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart J 2004; 148: 857-864.
17. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 2006; 114: 1955-1961. (Pubitemid 44665390)
18. Colombo A, Bramucci E, Sacca S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation 2009; 119: 71-78.
19. Hildick-Smith D, de Belder AJ, Cooter N, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: The British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation 2010; 121: 1235-1243.
20. Ge L, Tsagalou E, Iakovou I, Sangiorgi GM, Corvaja N, Airoldi F, Chieffo A, Montorfano M, Michev I, Colombo A,., In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005; 95: 757-760. (Pubitemid 40332657)
21. Collins N, Seidelin PH, Daly P, Ivanov J, Barolet A, Mackie K, Bui S, Schwartz L, Dzavik V,., Long-term outcomes after percutaneous coronary intervention of bifurcation narrowings. Am J Cardiol 2008; 102: 404-410.
22. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR, Jr,., Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000; 35: 929-936. (Pubitemid 30189924)
23. Aliabadi D, Tilli FV, Bowers TR, Benzuly KH, Safian RD, Goldstein JA, Grines CL, O'Neill WW,. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol 1997; 80: 994-997. (Pubitemid 27459196)
24. Assali AR, Assa HV, Ben-Dor I, Teplitsky I, Solodky A, Brosh D, Fuchs S, Kornowski R,. Drug-eluting stents in bifurcation lesions: To stent one branch or both? Catheter Cardiovasc Interv 2006; 68: 891-896. (Pubitemid 44847095)
25. Assali AR, Teplitsky I, Hasdai D, et al. Coronary bifurcation lesions: To stent one branch or both? J Invasive Cardiol 2004; 16: 447-450. (Pubitemid 39244887)
26. Burzotta F, Gwon HC, Hahn JY, Romagnoli E, Choi JH, Trani C, Colombo A,. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: The T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience. Catheter Cardiovasc Interv 2007; 70: 75-82. (Pubitemid 47035998)
27. Chen JL, Gao RL, Yang YJ, et al. Short and long-term outcomes of two drug eluting stents in bifurcation lesions. Chin Med J (Engl) 2007; 120: 183-186.
28. Di Mario C, Morici N, Godino C, et al. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients. Catheter Cardiovasc Interv 2007; 69: 416-424. (Pubitemid 46339286)
29. Diaz de la Llera LS, Ballesteros SM, Guisado A, Aguilera A, Campos A, Sanchez A, Villa M, Retegui G,. [Percutaneous treatment of bifurcation lesions by crush T stenting: immediate and medium-term outcomes]. Rev Esp Cardiol 2006; 59: 458-464.
30. Dzavik V, Kharbanda R, Ivanov J, Ing DJ, Bui S, Mackie K, Ramsamujh R, Barolet A, Schwartz L, Seidelin PH,. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. Am Heart J 2006; 152: 762-769. (Pubitemid 44396889)
31. Finci L, Ferraro M, Nishida T, Albiero R, Corvaja N, Vaghetti M, Stankovic G, Recchia M, Di Mario C, Colombo A,. Coronary stenting beyond standard indications. Immediate and follow-up results. Ital Heart J 2000; 1: 739-748.
32. Ge L, Cosgrave J, Iakovou I, et al. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions. Chin Med J (Engl) 2007; 120: 545-551. (Pubitemid 46629907)
33. Ge L, Iakovou I, Cosgrave J, et al. Treatment of bifurcation lesions with two stents: One year angiographic and clinical follow up of crush versus T stenting. Heart 2006; 92: 371-376.
34. Hoye A, Iakovou I, Ge L, van Mieghem CA, et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol 2006; 47: 1949-1958.
35. Hoye A, van Mieghem CA, Ong AT, et al. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: The Culotte technique revisited. Int J Cardiovasc Intervent 2005; 7: 36-40. (Pubitemid 40780426)
36. Kaplan S, Barlis P, Dimopoulos K, La Manna A, Goktekin O, Galassi A, Tanigawa J, Di Mario C,. Culotte versus T-stenting in bifurcation lesions: Immediate clinical and angiographic results and midterm clinical follow-up. Am Heart J 2007; 154: 336-343. (Pubitemid 47069130)
37. Kim YH, Park SW, Hong MK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97: 1597-1601.
38. Moussa I, Costa RA, Leon MB, et al. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique." Am J Cardiol 2006; 97: 1317-1321.
39. Naseer N, Varma R, Aronow WS, Monsen CE, Pucillo AL, Kalapatapu K, Weiss MB,. One-year mean follow-up of 41 patients treated with bifurcation stenting. Am J Ther 2007; 14: 46-48. (Pubitemid 46278669)
40. Pan M, Suarez de Lezo J, Medina A, et al. Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007; 153: 15 e1-e7.
41. Pan M, Suarez de Lezo J, Medina A, et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol 1999; 83: 1320-1325. (Pubitemid 29205739)
42. Prasan AM, Pitney MR, Ramsay D, Jepson NS, Friedman D, Taylor D, Giles RW,. New bifurcation stenting technique: Shunt stenting. Catheter Cardiovasc Interv 2004; 63: 474-481. (Pubitemid 39578512)
43. Rizik DG, Klassen KJ, Dowler DA, Villegas BJ,. Balloon alignment T-stenting for bifurcation coronary artery disease using the sirolimus-eluting stent. J Invasive Cardiol 2006; 18: 454-460. (Pubitemid 44497333)
44. Tanabe K, Hoye A, Lemos PA, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004; 94: 115-118. (Pubitemid 38813465)
45. Tsuchida K, Colombo A, Lefevre T, et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: Insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J 2007; 28: 433-442. (Pubitemid 47343573)
46. Valgimigli M, Malagutti P, Rodriguez Granillo GA, et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J 2006; 152: 896-902. (Pubitemid 44740157)
47. Vigna C, Biondi-Zoccai G, Amico CM, Lanna P, Stanislao M, Santoro T, Valle G, Fanelli R, Loperfido F,. Provisional T-drug-eluting stenting technique for the treatment of bifurcation lesions: Clinical, myocardial scintigraphy and (late) coronary angiographic results. J Invasive Cardiol 2007; 19: 92-97. (Pubitemid 46362788)
48. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: Two stents versus one stentâimmediate and follow-up results. J Am Coll Cardiol 2000; 35: 1145-1151. (Pubitemid 30206888)
49. Adriaenssens T, Byrne RA, Dibra A, Iijima R, Mehilli J, Bruskina O, Schomig A, Kastrati A,. Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes. Eur Heart J 2008; 29: 2868-2876.
50. Chen SL, Zhang JJ, Ye F, Chen YD, Patel T, Kawajiri K, Lee M, Kwan TW, Mintz G, Tan HC,. Study comparing the double kissing (DK) crush with classical crush for the treatment of coronary bifurcation lesions: the DKCRUSH-1 Bifurcation Study with drug-eluting stents. Eur J Clin Invest 2008; 38: 361-371. (Pubitemid 351712922)
51. Erglis A, Kumsars S, Niemela M, et al. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The Nordic Stent Technique Study. Circ Cardiovasc Intervent 2009; 2: 27-34.
52. Galassi AR, Tomasello SD, Capodanno D, Barrano G, Ussia GP, Tamburino C,. Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents. JACC Cardiovasc Interv 2009; 2: 185-194.
53. Hildick-Smith D,. BBC ONE British Bifurcation Coronary Study: Old, New, and Evolving Strategies trial. Presented at Transcatheter Cardiovascular Therapeutics. Washington, DC: October 2008.
54. Jensen JS, Galloe A, Lassen JF, et al. Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results. EuroIntervention 2008; 4: 229-233.
55. Palmerini T, Marzocchi A, Tamburino C, et al. Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents. Circ Cardiovasc Intervent 2008; 1: 185-192.
56. Yang HM, Tahk SJ, Woo SI, et al. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions. Catheter Cardiovasc Interv 2009.
57. Zamani P, Kinlay S,. Long-term outcomes following percutaneous interventions of coronary artery bifurcation lesions depend on procedural and traditional atherosclerotic risk factors. J Am Coll Cardiol 2008; 51 (Suppl B): B50-B51.
58. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351. (Pubitemid 46685903)
59. Alpert JS, Thygesen K, Antman E, Bassand JP,. Myocardial infarction redefinedâa consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
60. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47: e1-e121. (Pubitemid 43005195)
61. Agresti A, Coull BA,. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 1998; 52: 119-126.
62. Newcombe RG,. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857-872. (Pubitemid 28185165)
63. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC,. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2008; 51: 607-614. (Pubitemid 351193101)
64. Marroquin OC, Selzer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008; 358: 342-352. (Pubitemid 351159233)
65. Brodie BR, Stuckey T, Downey W, et al. Outcomes and complications with off-label use of drug-eluting stents: Results from the STENT (Strategic Transcatheter Evaluation of New Therapies) Group. J Am Coll Cardiol Intv 2008; 1: 405-414.
66. Latib A, Colombo A, Sangiorgi G,. Bifurcation stenting: Current Strategies and New Devices. Heart 2009; 95: 495-504.
67. Waksman R, Bonello L,. The 5 Ts of bifurcation intervention; type, technique, two stents, t-stenting, trials. J Am Coll Cardiol Intv 2008; 1: 366-368.
68. Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J 2008; 29: 726-732.